FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Strides Pharma Children's Ibuprofen Oral Suspension Recall

Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Man…

STRIDES PHARMA INC · Bridgewater, NJ

Risk level
Class II
Reported by FDA
Mar 25, 2026
Recall ID
D-0390-2026
Check your lot numberHow we source this data

Summary

Strides Pharma recalled Children's Ibuprofen Oral Suspension starting Mar 2, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0390-2026 on Mar 25, 2026. Reason: Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product. Status: Ongoing.

Why it was recalled

Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.

Product description

Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, Made in India, NDC 51672-5321-8.

Lot numbers, UPCs & expiration codes

Lot: 7261973A, 7261974A, Exp 01/31/2027

Where it was sold

U.S.A. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0390-2026
Classification
Class II
Status
Ongoing
Recall initiated
Mar 2, 2026
FDA report date
Mar 25, 2026
Quantity
89592 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
STRIDES PHARMA INC

Original FDA data

Every field from FDA enforcement report D-0390-2026, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Ongoing
Country
United States
Event ID
98508
Address
200 Crossing Blvd Ste 110
Code information
Lot: 7261973A, 7261974A, Exp 01/31/2027
Postal code
08807-2861
Report date
Mar 25, 2026
Product type
Drugs
Recall number
D-0390-2026
Classification
Class II
Recalling firm
STRIDES PHARMA INC
Product quantity
89592 bottles
Reason for recall
Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, Made in India, NDC 51672-5321-8.
Distribution pattern
U.S.A. Nationwide
Recall initiation date
Mar 2, 2026
Initial firm notification
Letter
Center classification date
Mar 16, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0390-2026, published Mar 25, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls